Slideshow

sTMS Device May Prevent Migraine

A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Souvik Sen, MD, MPH, FAHA
Elizabeth W. Leroux, MD, FRCPC
© 2025 MJH Life Sciences

All rights reserved.